keyword
https://read.qxmd.com/read/38626830/resveratrol-alleviates-acute-lung-injury-in-mice-by-promoting-pink1-parkin-related-mitophagy-and-inhibiting-nlrp3-inflammasome-activation
#1
JOURNAL ARTICLE
Dongdong Wu, Hui Zhang, Fang Li, Shuai Liu, Yang Wang, Zhao Zhang, Jiannan Wang, Qiuge Wu
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by rapid onset and widespread inflammation in the lungs, often leading to respiratory failure. These conditions can be triggered by various factors, resulting in a severe inflammatory response within the lungs. Resveratrol, a polyphenolic compound found in grapes and peanuts, is renowned for its potent antioxidative and anti-inflammatory properties. In this study, we investigated how resveratrol protects against lipopolysaccharide (LPS)-induced ALI in mice...
April 14, 2024: Biochimica et Biophysica Acta. General Subjects
https://read.qxmd.com/read/38626523/design-synthesis-and-evaluation-of-a-pyrazolo-3-4-d-pyrimidine-derivative-as-a-novel-and-potent-tgf%C3%AE-1r1-inhibitor
#2
JOURNAL ARTICLE
Yubo Wang, Yulin Liu, Yan Zhang, Zixuan Zhang, Lei Xu, Jiefu Wang, Yijie Yang, Biyu Hu, Yuhong Yao, Mingming Wei, Junfeng Wang, Bencan Tang, Kun Zhang, Shuangwei Liu, Guang Yang
The transforming growth factor β1 (TGFβ1)/SMAD signaling pathway regulates many vital physiological processes. The development of potent inhibitors targeting activin receptor-like kinase 5 (ALK5) would provide potential treatment reagents for various diseases. A significant number of ALK5 inhibitors have been discovered, and they are currently undergoing clinical evaluation at various stages. However, the clinical demands were far from being met. In this study, we utilized an alternative conformation-similarity-based virtual screening (CSVS) combined with a fragment-based drug designing (FBDD) strategy to efficiently discover a potent and active hit with a novel chemical scaffold...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38624258/exploring-anticancer-properties-of-medicinal-plants-against-breast-cancer-by-downregulating-human-epidermal-growth-factor-receptor-2
#3
JOURNAL ARTICLE
Sunny Gupta, Rashima Prem, Chinmayee Sethy, Saurabh Shrivastava, Manju Singh, Pramod Yadav, V G Huddar, P K Prajapati, Anita Roy, Monica Sundd, Ashok Kumar Patel
Plants have a history of being employed in managing breast cancer. However, no scientific evidence supports the idea that these plants can effectively reduce the level of HER2 expression. In this study, extracts from 10 medicinal plants were evaluated for their anticancer properties against HER2-positive breast cancer cells through various methods, including the SRB assay, comet assay, annexin V-FITC dual staining, and immunoblotting. All extracts exerted antiproliferative activity against HER2-positive breast cancer cells...
April 16, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38621994/-identification-of-1-3-8-triazaspiro-4-5-decane-2-4-dione-derivatives-as-a-novel-delta-opioid-receptor-selective-agonist-chemotype
#4
JOURNAL ARTICLE
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Delta opioid receptors hold potential as a target for neurological and psychiatric disorders, yet no delta opioid receptor agonist has proven efficacious in critical phase II clinical trials. The exact reasons for the failure to produce quality drug candidates for the delta opioid receptor is nuclear. However, it is known that certain delta opioid receptor agonists can induce seizures and exhibit tachyphylaxis. Several studies have suggested that those adverse effects are more prevalent in delta agonists that share the SNC80/BW373U86 chemotype...
April 15, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38618977/design-synthesis-and-biological-evaluation-of-novel-3c-like-protease-inhibitors-as-lead-compounds-against-sars-cov-2
#5
JOURNAL ARTICLE
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li
Background: The epidemic caused by SARS-CoV-2 swept the world in 2019. The 3C-like protease (3CLpro) of SARS-CoV-2 plays a key role in viral replication, and its inhibition could inhibit viral replication. Materials & methods: The virtual screen based on receptor-ligand pharmacophore models and molecular docking were conducted to obtain the novel scaffolds of the 3CLpro. The molecular dynamics simulation was also carried out. All compounds were synthesized and evaluated in biochemical assays. Results: The compound C2 could inhibit 3CLpro with a 72% inhibitory rate at 10 μM...
April 15, 2024: Future Medicinal Chemistry
https://read.qxmd.com/read/38617664/identification-of-novel-quinolone-and-quinazoline-alkaloids-as-phosphodiesterase-10a-inhibitors-for-parkinson-s-disease-through-a-computational-approach
#6
JOURNAL ARTICLE
Iqra Ahmad, Hira Khalid, Asia Perveen, Muhammad Shehroz, Umar Nishan, Faiz Ur Rahman, Sheheryar, Arlindo Alencar Moura, Riaz Ullah, Essam A Ali, Mohibullah Shah, Suvash Chandra Ojha
Phosphodiesterases (PDEs) are vital in signal transduction, specifically by hydrolyzing cAMP and cGMP. Within the PDE family, PDE10A is notable for its prominence in the striatum and its regulatory function over neurotransmitters in medium-spiny neurons. Given the dopamine deficiency in Parkinson's disease (PD) that affects striatal pathways, PDE10A inhibitors could offer therapeutic benefits by modulating D1 and D2 receptor signaling. This study was motivated by the successful history of quinazoline/quinazoline scaffolds in the inhibition of PDE10A...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38617602/new-theobromine-apoptotic-analogue-with-anticancer-potential-targeting-the-egfr-protein-computational-and-in-vitro-studies
#7
JOURNAL ARTICLE
Ibrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, Aisha A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Ahmed Ismail, Hazem Elkady, Ahmed M Metwaly
AIM: The aim of this study was to design and examine a novel epidermal growth factor receptor (EGFR) inhibitor with apoptotic properties by utilizing the essential structural characteristics of existing EGFR inhibitors as a foundation. METHOD: The study began with the natural alkaloid theobromine and developed a new semisynthetic derivative ( T-1-PMPA ). Computational ADMET assessments were conducted first to evaluate its anticipated safety and general drug-likeness...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38617237/modulation-of-endogenous-opioid-signaling-by-inhibitors-of-puromycin-sensitive-aminopeptidase
#8
Rohit Singh, Rongrong Jiang, Jessica Williams, Prakashkumar Dobariya, Filip Hanak, Jiashu Xie, Patrick E Rothwell, Robert Vince, Swati S More
The endogenous opioid system regulates pain through local release of neuropeptides and modulation of their action on opioid receptors. However, the effect of opioid peptides, the enkephalins, is short-lived due to their rapid hydrolysis by enkephalin-degrading enzymes. In turn, an innovative approach to the management of pain would be to increase the local concentration and prolong the stability of enkephalins by preventing their inactivation by neural enkephalinases such as puromycin sensitive aminopeptidase (PSA)...
April 3, 2024: bioRxiv
https://read.qxmd.com/read/38615917/isobavachin-attenuates-osteoclastogenesis-and-periodontitis-induced-bone-loss-by-inhibiting-cellular-iron-accumulation-and-mitochondrial-biogenesis
#9
JOURNAL ARTICLE
Ting Li, Yangge Du, Hantao Yao, Boxuan Zhao, Zijun Wang, Rourong Chen, Yaoting Ji, Minquan Du
As bone-resorbing cells rich in mitochondria, osteoclasts require high iron uptake to promote mitochondrial biogenesis and maintain a high-energy metabolic state for active bone resorption. Given that abnormal osteoclast formation and activation leads to imbalanced bone remodeling and osteolytic bone loss, osteoclasts may be crucial targets for treating osteolytic diseases such as periodontitis. Isobavachin (IBA), a natural flavonoid compound, has been confirmed to be an inhibitor of receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation from bone marrow-derived macrophages (BMMs)...
April 12, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38615365/quercetin-alleviates-chronic-unpredictable-mild-stress-induced-depression-like-behavior-by-inhibiting-nmdar1-with-%C3%AE-2%C3%AE-1-in-rats
#10
JOURNAL ARTICLE
Mingyan Wang, Xin Wei, Yugai Jia, Chaonan Wang, Xinliu Wang, Xin Zhang, Depei Li, Yuanyuan Wang, Yonggang Gao
BACKGROUND: Depression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Chronic unpredictable mild stress (CUMS) can lead to a significant acceleration of depression development. Quercetin (Que) is a flavonoid compound with a wide range of pharmacological effects. Recent studies have shown that quercetin can improve CUMS-induced depression-like behavior, but the mechanism of its improvement is still unclear. α2δ-1 is a regulatory subunit of voltage-gated calcium channel, which can interact with N-methyl-D-aspartate receptor (NMDAR) to form a complex...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38614067/covalent-docking-driven-virtual-screening-of-extensive-small-molecule-libraries-against-bruton-tyrosine-kinase-for-the-identification-of-highly-selective-and-potent-novel-therapeutic-candidates
#11
JOURNAL ARTICLE
Ezgi Sambur, Lalehan Oktay, Serdar Durdağı
Bruton tyrosine kinases (BTKs) play critical roles in various diseases, including chronic lymphatic leukemia (CLL), Waldenström Macroglobulinemia, Marginal Zone Lymphoma, Mantle Cell Lymphoma (MCL), and Graft Versus Host diseases. BTKs are a family of tyrosine kinases involved in B lymphocyte signal transduction, development, and maturation. Their overexpression can lead to cancer as they are essential for the activation of the B Cell Receptor (BCR) signaling pathway. Blocking the activation of BTKs presents a promising approach for treating CLL...
April 4, 2024: Journal of Molecular Graphics & Modelling
https://read.qxmd.com/read/38613643/discovery-of-a-novel-shp2-allosteric-inhibitor-using-virtual-screening-fmo-calculation-and-molecular-dynamic-simulation
#12
JOURNAL ARTICLE
Zhen Yuan, Manzhan Zhang, Longfeng Chang, Xingyu Chen, Shanshan Ruan, Shanshan Shi, Yiqing Zhang, Lili Zhu, Honglin Li, Shiliang Li
CONTEXT: SHP2 is a non-receptor protein tyrosine phosphatase to remove tyrosine phosphorylation. Functionally, SHP2 is an essential bridge to connect numerous oncogenic cell-signaling cascades including RAS-ERK, PI3K-AKT, JAK-STAT, and PD-1/PD-L1 pathways. This study aims to discover novel and potent SHP2 inhibitors using a hierarchical structure-based virtual screening strategy that combines molecular docking and the fragment molecular orbital method (FMO) for calculating binding affinity (referred to as the Dock-FMO protocol)...
April 13, 2024: Journal of Molecular Modeling
https://read.qxmd.com/read/38611867/design-synthesis-and-evaluation-of-b-trifluoromethyl-phenyl-phosphine-borane-derivatives-as-novel-progesterone-receptor-antagonists
#13
JOURNAL ARTICLE
Yu Miyajima, Kotaro Ochiai, Shinya Fujii
We previously revealed that phosphine-boranes can function as molecular frameworks for biofunctional molecules. In the present study, we exploited the diversity of available phosphines to design and synthesize a series of B -(trifluoromethyl)phenyl phosphine-borane derivatives as novel progesterone receptor (PR) antagonists. We revealed that the synthesized phosphine-borane derivatives exhibited Log P values in a predictable manner and that the P-H group in the phosphine-borane was almost nonpolar. Among the synthesized phosphine-boranes, which exhibited PR antagonistic activity, B -(4-trifluoromethyl)phenyl tricyclopropylphosphine-borane was the most potent with an IC50 value of 0...
April 2, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38611825/channel-expansion-in-the-ligand-binding-domain-of-the-glucocorticoid-receptor-contributes-to-the-activity-of-highly-potent-glucocorticoid-analogues
#14
JOURNAL ARTICLE
Wesley B Seaton, Susan J Burke, Alexander R Fisch, William A Schilletter, Mary Grace A Beck, Gabrielle A Cassagne, Innocence Harvey, Molly S Fontenot, J Jason Collier, Shawn R Campagna
Glucocorticoids (GCs) act through the glucocorticoid receptor (GR) and are commonly used as anti-inflammatory and immunosuppressant medications. Chronic GC use has been linked with unwanted complications such as steroid-induced diabetes mellitus (SIDM), although the mechanisms for these effects are not completely understood. Modification of six GC parent molecules with 2-mercaptobenzothiazole resulted in consistently less promoter activity in transcriptional activation assays using a 3xGRE reporter construct while constantly reducing inflammatory pathway activity...
March 29, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38611824/analgesic-peptides-from-natural-diversity-to-rational-design
#15
REVIEW
Katarzyna Gach-Janczak, Monika Biernat, Mariola Kuczer, Anna Adamska-Bartłomiejczyk, Alicja Kluczyk
Pain affects one-third of the global population and is a significant public health issue. The use of opioid drugs, which are the strongest painkillers, is associated with several side effects, such as tolerance, addiction, overdose, and even death. An increasing demand for novel, safer analgesic agents is a driving force for exploring natural sources of bioactive peptides with antinociceptive activity. Since the G protein-coupled receptors (GPCRs) play a crucial role in pain modulation, the discovery of new peptide ligands for GPCRs is a significant challenge for novel drug development...
March 29, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38608255/flavan-3-ols-flavonoids-anthocyanidins-and-triterpenoids-induces-tie2-phosphorylation-a-candidate-target-for-the-vascular-protective-effects
#16
JOURNAL ARTICLE
Saki Igarashi, Sayaka Hioki, Naoto Sakamaru, Asahi Suzuki, Mihoko Kurokawa, Eisuke Kato
Vascular system is essential for the body to maintain health. Dysregulated vascular system leads to cardiovascular diseases and are observed in ischaemic stroke, Alzheimer's disease, amyotrophic lateral sclerosis, and diabetes. TIE2 is a tyrosine kinase receptor expressed on vascular endothelial cells and contributes to the maintenance of a vascular system. In this paper, we screened for natural products with an activity to induce phosphorylation of TIE2, which will be beneficial for protection of a vascular system...
April 12, 2024: Natural Product Research
https://read.qxmd.com/read/38605072/design-synthesis-biological-assessment-and-molecular-modeling-studies-of-novel-imidazothiazole-thiazolidinone-hybrids-as-potential-anticancer-and-anti-inflammatory-agents
#17
JOURNAL ARTICLE
Payal Kamboj, Anjali, Khalid Imtiyaz, Moshahid A Rizvi, Virendra Nath, Vipin Kumar, Asif Husain, Mohd Amir
A new series of imidazothiazole derivatives bearing thiazolidinone moiety (4a-g and 5a-d) were designed, synthesized and evaluated for potential epidermal growth factor receptor (EGFR) kinase inhibition, anticancer and anti-inflammatory activity, cardiomyopathy toxicity and hepatotoxicity. Compound 4c inhibited EGFR kinase at a concentration of 18.35 ± 1.25 µM, whereas standard drug erlotinib showed IC50 value of 06.12 ± 0.92 µM. The molecular docking, dynamics simulation and MM-GBSA binding energy calculations revealed strong interaction of compound 4c with binding site of EGFR...
April 11, 2024: Scientific Reports
https://read.qxmd.com/read/38602108/phytoestrogens-chemistry-potential-health-benefits-and-their-medicinal-importance
#18
REVIEW
Vivek P Chavda, Amit Z Chaudhari, Pankti C Balar, Amol Gholap, Lalitkumar K Vora
Phytoestrogens, also known as xenoestrogens, are secondary metabolites derived from plants that have similar structures and biological effects as human estrogens. These compounds do not directly affect biological functions but can act as agonists or antagonists depending on the level of endogenous estrogen in the body. Phytoestrogens may have an epigenetic mechanism of action independent of estrogen receptors. These compounds are found in more than 300 plant species and are synthesized through the phenylpropanoid pathway, with specific enzymes leading to various chemical structures...
April 11, 2024: Phytotherapy Research: PTR
https://read.qxmd.com/read/38601803/discovery-of-potential-epidermal-growth-factor-receptor-inhibitors-from-black-pepper-for-the-treatment-of-lung-cancer-an-in-silico-approach
#19
JOURNAL ARTICLE
Olusola Olalekan Elekofehinti, Ifeoluwa Rachael Adetoyi, Hannah Oluwaseun Popoola, Folasade Oluwatobiloba Ayodeji, Foluso Adeola Taiwo, Moses Orimoloye Akinjiyan, Omowunmi Funmilayo Koledoye, Opeyemi Iwaloye, Abayomi Emmanuel Adegboyega
UNLABELLED: A tyrosine kinase receptor known as epidermal growth factor receptor (EGFR) is one of the main tumour markers in many cancer types and also plays a crucial role in cell proliferation, differentiation, angiogenesis, and apoptosis, which is a result of the auto-phosphorylations (kinase activity enhancement) that trigger signals involved in different cellular processes. Due to the discovery that non-small cell lung cancer (NSCLC) is a cause of this kinase activity enhancement, so far, several inhibitors have been tested against EGFR, but the side effects of these inhibitors necessitate an urgent measure to come up with an inhibitor that will be more specific to the cancer cells and not affect self-cells...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38598723/virtual-screening-of-a-chemically-diverse-superscaffold-library-enables-ligand-discovery-for-a-key-gpcr-target
#20
JOURNAL ARTICLE
Katharina Grotsch, Anastasiia V Sadybekov, Sydney Hiller, Saheem Zaidi, Dmitry Eremin, Austen Le, Yongfeng Liu, Evan Carlton Smith, Christos Illiopoulis-Tsoutsouvas, Joice Thomas, Shubhangi Aggarwal, Julie E Pickett, Cesar Reyes, Elias Picazo, Bryan L Roth, Alexandros Makriyannis, Vsevolod Katritch, Valery V Fokin
The advent of ultra-large libraries of drug-like compounds has significantly broadened the possibilities in structure-based virtual screening, accelerating the discovery and optimization of high-quality lead chemotypes for diverse clinical targets. Compared to traditional high-throughput screening, which is constrained to libraries of approximately one million compounds, the ultra-large virtual screening approach offers substantial advantages in both cost and time efficiency. By expanding the chemical space with compounds synthesized from easily accessible and reproducible reactions and utilizing a large, diverse set of building blocks, we can enhance both the diversity and quality of the discovered lead chemotypes...
April 10, 2024: ACS Chemical Biology
keyword
keyword
165227
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.